Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
562-04-012 ISMRM Abstract

Gadolinium-Free MR Perfusion Imaging Based on Generative Adversarial Network for Primary Intracranial Tumor Diagnosis

Primary: Contrast Mechanisms - Contrast Agents
Secondary: Pediatrics - Neuro
562-04-012 · AI/DL in Pediatrics · Wednesday, 13 May, 2:35 PM–3:30 PM · Digital Posters Row C
Keywords: DSC & DCE Perfusion Deep learning reconstruction Dynamic contrast enhanced MRI Non-contrast-enhanced Brain Tumor Imaging
Accepted
Guoqi Lin1, Lukui Xiong 1, Jiahao Tao1, Yihua Chen2, Junhuan Hong1, Yuwei Pan1, Pingping He1, Wei Guo1, Yan Su1, Ming Chen1, Yang Song3, Dejun She1,4
1Department of Radiology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China
2School of Medical Imaging, Fujian Medical University, Fuzhou, China
3MR Research Collaboration, Shanghai, China
4Department of Radiology, Key Laboratory of Radiation Biology of Fujian higher education institutions, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China
Presenting Author: Lukui Xiong

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Jain RK, Di Tomaso E, Duda DG, Loeffler JS, Sorensen AG, Batchelor TT. Angiogenesis in brain tumours. Nat Rev Neurosci. 2007;8(8):610–622
2. Choi KS, Hwang I, Park CK, Park SH, Choi SH. New subependymal enhancement after radiation therapy in high‐grade glioma: Utilizing morphological features and DSC perfusion MRI in differentiate progression and post‐radiation changes. J Magn Reson Imaging. 2025;61(4):1751–1760
3. Pons-Escoda A, Garcia-Ruiz A, Naval-Baudin P, et al. Differentiating IDH-mutant astrocytomas and 1p19q-codeleted oligodendrogliomas using DSC-PWI: High performance through cerebral blood volume and percentage of signal recovery percentiles. Eur Radiol. 2024;34(8):5320–5330.
4. Rudnick MR, Wahba IM, Leonberg-Yoo AK, Miskulin D, Litt HI. Risks and Options With Gadolinium-Based Contrast Agents in Patients With CKD: A Review. Am J Kidney Dis. 2021;77(4):517–528.
5. Kanda T, Osawa M, Oba H, et al. High Signal Intensity in Dentate Nucleus on Unenhanced T1-weighted MR Images: Association with Linear versus Macrocyclic Gadolinium Chelate Administration. Radiology. 2015;275(3):803–809.
6. McDonald RJ, Levine D, Weinreb J, et al. Gadolinium Retention: A Research Roadmap from the 2018 NIH/ACR/RSNA Workshop on Gadolinium Chelates. Radiology. 2018;289(2):517–534
7. olak M, Tören M, Asan B, Kaba E, Beyazal M, Çeliker FB. Generative adversarial network based contrast enhancement: Synthetic contrast brain magnetic resonance imaging. Acad Radiol. 2025;32(4):2220–2232.
8. Yang X, Xing Z, She D, et al. Grading of IDH-mutant astrocytoma using diffusion, susceptibility and perfusion-weighted imaging. Bmc Med Imaging. 2022;22(1):105.
9. Tudela Martínez JI, Vázquez Sáez V, Carbonell G, Rodrigo Lara H, Guzmán-Aroca F, Berna Mestre JDD. Diagnostic utility of intratumoral susceptibility signals in adult diffuse gliomas: Tumor grade prediction and correlation with molecular markers within the WHO CNS5 (2021) classification. J Clin Med. 2025;14(11):4004.
10. Cindil E, Sendur HN, Cerit MN, et al. Prediction of IDH mutation status in high-grade gliomas using DWI and high T1-weight DSC-MRI. Acad Radiol.2022;29:S52–S62.
11. Bakas S, Sako C, Akbari H, et al. The University of Pennsylvania glioblastoma (UPenn-GBM) cohort: advanced MRI, clinical, genomics, & radiomics. Sci Data. 2022;9(1):453.
12. Karras T, Laine S, Aittala M, Hellsten J, Lehtinen J, Aila T. Analyzing and Improving the Image Quality of StyleGAN. 2020 IEEECVF Conf Comput Vis Pattern Recognit CVPR. Seattle, WA, USA: IEEE; 2020. p. 8107–8116.
13. Ronneberger O, Fischer P, Brox T. U-net: Convolutional networks for biomedical image segmentation. arXiv; 2015.
14. Lopes L, Jiao F, Xue S, et al. Dopaminergic PET to SPECT domain adaptation: A cycle GAN translation approach. Eur J Nucl Med Mol Imaging. 2025;52(3):851–863.
15. Hirschler L, Sollmann N, Schmitz‐Abecassis B, et al. Advanced MR techniques for preoperative glioma characterization: part 1. J Magn Reson Imaging. 2023;57(6):1655–1675.
16. Gao A, Zhang H, Yan X, et al. Whole-tumor histogram analysis of multiple diffusion metrics for glioma genotyping. Radiology. 2022;302(3):652–661.

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/562-04-012